Oligonucleotidic therapeutics

Author： Isaka Yoshitaka   Imai Enyu   Takahara Shiro   Rakugi Hiromi  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.3, Iss.9, 2008-09, pp. : 991-996

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prodrugs as therapeutics

By Stella Valentino J  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 3, 2004-03 ,pp. : 277-280

Informa Healthcare

Access to resources Recommend Favorite

Opinion and Evidence in Cardiovascular Therapeutics

By  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 1, 2002-01 ,pp. : 59-67

Adis International

Access to resources Recommend Favorite

Opinion and Evidence in Cardiovascular Therapeutics

By Adis International Limited  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 4, 2003-01 ,pp. : 299-307

Adis International

Access to resources Recommend Favorite

Opinion and Evidence in Cardiovascular Therapeutics

By  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 5, 2002-01 ,pp. : 345-353

Adis International

Access to resources Recommend Favorite

Opinion and Evidence in Cardiovascular Therapeutics

By  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 2, 2003-01 ,pp. : 139-148

Adis International

Access to resources Recommend Favorite